Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
Not Confirmed
Not Confirmed
03-05 June, 2026
Peptide Therapeutics F...Peptide Therapeutics Forum 2026
Not Confirmed
Not Confirmed
04-05 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
Industry Trade Show
Not Confirmed
03-05 June, 2026
Peptide Therapeutics F...Peptide Therapeutics Forum 2026
Industry Trade Show
Not Confirmed
04-05 June, 2026
Digital content

31 May 2026
// PRESS RELEASE
https://www.jnj.com/media-center/press-releases/rybrevant-faspro-amivantamab-and-hyaluronidase-lpuj-pivotal-data-show-strong-and-durable-responses-in-advanced-head-and-neck-cancer-where-options-remain-limited

31 May 2026
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/jj-prostate-cancer-drug-reduces-risk-cancer-spread-death-late-stage-study-2026-05-31/

29 May 2026
// PRESS RELEASE
https://www.jnj.com/media-center/press-releases/rybrevant-amivantamab-vmjw-plus-lazcluze-lazertinib-demonstrates-prolonged-clinical-benefit-as-a-first-line-treatment-for-atypical-egfr-mutated-non-small-cell-lung-cancer

29 May 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/new-tecvayli-teclistamab-cqyv-data-demonstrate-superior-progression-free-and-overall-survival-as-early-as-first-relapse-in-multiple-myeloma-302785621.html

28 May 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-approves-label-expansion-cementing-tremfya-as-the-only-il23-inhibitor-proven-to-help-stop-further-joint-damage-302785103.html

27 May 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260527068310/en/Johnson-Johnson-to-Host-Investor-Conference-Call-on-Second-Quarter-Results
Excipients
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
Johnson & Johnson is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find Nicotine bulk with DMF offered by Johnson & Johnson
Find Naloxone Hydrochloride bulk offered by Johnson & Johnson
Find Sodium Hyaluronate bulk offered by Johnson & Johnson